Market Overview
According to Novatrends Market Intelligence, the Global Enteral Single Use Syringe Market was valued at USD 1.24 billion in 2025 and is anticipated to propel at a growth rate of 6.8% from 2026-2036.
The enteral single use syringe market provides oral enteral syringe, nasogastric enteral syringe, jejunal enteral syringe, and ENFit enteral syringe products for safe delivery of enteral nutrition, medications, and fluids to patients who cannot swallow normally, including ICU patients, stroke patients, premature neonates, and home care patients with chronic conditions. Single use enteral syringe products are manufactured from polypropylene enteral syringe material for chemical resistance to tube feed formulas and medications, with graduated markings for accurate volume measurement. ENFit enteral syringe products comply with the ISO 80369-3 standard (ISO 80369 enteral syringe) using the ENFit connector system specifically designed for enteral feeding to prevent dangerous misconnections between enteral and intravenous routes that can result in patient fatality. Enteral syringe with ENFit connector has become the mandated standard globally, replacing legacy luer-lock enteral syringe and luer-slip enteral connectors in hospital and home care settings. The 60ml enteral syringe is the most commonly used volume in adult nasogastric enteral syringe administration, while 10ml and 20ml enteral syringe for pediatric use serve neonatal and pediatric enteral nutrition and medication delivery. Enteral feeding syringe products are used in hospitals for bolus enteral nutrition delivery through NG tubes, PEG tubes, and jejunostomy tubes. Enteral syringe for home care is growing rapidly as home enteral nutrition (HEN) programs expand globally for discharged patients and chronic disease management. Enteral nutrition syringe demand is driven by growing critically ill patient populations, neurological disease prevalence (ALS, stroke, Parkinson's), and premature neonatal enteral feeding programs. Enteral syringe manufacturer competition includes BD, B. Braun, ICU Medical, and NeoMed. Enteral single use syringe market size is growing with aging population, ICU bed expansion, and home enteral nutrition program growth globally.
Market Dynamics
The market is driven by mandatory global transition from legacy luer-lock enteral syringe to ENFit enteral syringe and ISO 80369 enteral syringe standards following patient safety misconnection incidents, growing aging population and chronic neurological disease prevalence creating sustained enteral nutrition syringe and enteral feeding syringe demand in hospitals and home care, and home enteral nutrition program expansion requiring enteral syringe for home care with user-friendly oral enteral syringe designs. ENFit enteral syringe adoption is now mandated by most hospital systems in North America, Europe, and Australia, with remaining markets transitioning. Enteral syringe for pediatric use demand is growing with NICU expansion and pediatric home enteral nutrition programs. Enteral single use syringe market trends show growing home care segment as hospitals discharge stable tube-fed patients earlier. Enteral syringe market consolidation is ongoing with BD and B. Braun holding significant enteral single use syringe market shares. Polypropylene enteral syringe material is standard due to chemical compatibility. Enteral single use syringe market growth is supported by healthcare infrastructure expansion in Asia Pacific and Latin America. In January 2024, BD expanded ENFit enteral syringe and ISO 80369 enteral syringe with Alaris enteral and oral enteral syringe line extensions, while B. Braun advanced nasogastric enteral syringe and enteral feeding syringe with Omnifix enteral single use syringe for hospital and home care markets. Enteral single use syringe market trends show strong ENFit connector adoption accelerating globally.
Segment Analysis
By Type: Oral Enteral Syringe holds the largest share of the Enteral Single Use Syringe market, supported by strong adoption and well-established supply chains across key end-use industries. Nasogastric Enteral Syringe is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.
By Material: Polypropylene Enteral Syringe holds the largest share of the Enteral Single Use Syringe market, supported by strong adoption and well-established supply chains across key end-use industries. Polyethylene Enteral Syringe is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.
By Application: Enteral Nutrition holds the largest share of the Enteral Single Use Syringe market, supported by strong adoption and well-established supply chains across key end-use industries. Medication Administration is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.
By End-Use: Hospitals holds the largest share of the Enteral Single Use Syringe market, supported by strong adoption and well-established supply chains across key end-use industries. Home Care is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

Recent Developments in Enteral Single Use Syringe Market
- In January 2024, Becton Dickinson (BD) expanded ENFit enteral syringe and ISO 80369 enteral syringe with oral enteral syringe and nasogastric enteral syringe line extensions, advancing enteral feeding syringe, 60ml enteral syringe, and enteral syringe with ENFit connector for hospital ICU and enteral syringe for home care programs globally.
- In April 2024, B. Braun Melsungen AG advanced nasogastric enteral syringe and ENFit enteral syringe with Omnifix enteral single use syringe innovations, launching polypropylene enteral syringe, enteral nutrition syringe, and enteral syringe for pediatric use for hospital and home enteral nutrition market growth programs globally.
- In July 2024, ICU Medical Inc. expanded enteral feeding syringe and single use enteral syringe with ENFit enteral syringe and ISO 80369 enteral syringe-compliant product line, advancing oral enteral syringe, jejunal enteral syringe, and enteral syringe market growth for hospital ICU, long-term care, and enteral syringe for home care applications.
- In September 2024, NeoMed Inc. (Avanos Medical) advanced enteral syringe for pediatric use and ENFit enteral syringe with NeoMed neonatal oral enteral syringe and NICU-specific enteral feeding syringe innovations, expanding enteral single use syringe market with polypropylene enteral syringe, enteral nutrition syringe, and enteral syringe with ENFit connector for pediatric hospital and home care programs.
- In December 2024, Vygon SA (France) expanded nasogastric enteral syringe and enteral single use syringe with ENFit enteral syringe and ISO 80369 enteral syringe innovations, advancing 60ml enteral syringe, enteral feeding syringe, and enteral syringe for home care for European hospital, home care, and long-term care enteral syringe market growth.
- In March 2025, Cardinal Health Inc. advanced enteral nutrition syringe and single use enteral syringe with ENFit enteral syringe and polypropylene enteral syringe supply chain expansion, growing enteral single use syringe market size with oral enteral syringe, enteral syringe for pediatric use, and enteral syringe market growth programs for North American hospital and home care enteral feeding syringe distribution channels.
Top Enteral Single Use Syringe Market - Key Market Players
- Becton Dickinson (BD)
- B. Braun Melsungen AG
- ICU Medical Inc.
- NeoMed (Avanos Medical)
- Vygon SA
- Cardinal Health Inc.
- Amsino Medical Group
- Kangaroo (Avanos Medical)
- Covidien (Medtronic)
- Smiths Medical (ICU Medical)
- Fresenius Kabi AG
- Baxter International Inc.
- Merit Medical Systems
- Moog Medical Devices
- Corpak MedSystems
Global Enteral Single Use Syringe Market Report- Scope (Customizable)
Scope | Description |
Historic Period | 2021-2024 |
Base Year (Esti.) | 2025 |
Forecast Period (F) | 2026-2036 |
Market Values | USD Billion |
By Type | Oral Enteral Syringe, Nasogastric Enteral Syringe, Jejunal Enteral Syringe, ENFit Enteral Syringe |
By Material | Polypropylene Enteral Syringe, Polyethylene Enteral Syringe |
By Application | Enteral Nutrition, Medication Administration, Fluid Therapy |
By End-Use | Hospitals, Home Care, Long-Term Care, Pediatric Clinics |
Market by Region | North America (NA), Europe (EUR), Asia Pacific (APAC), Central & South America (CSA), and Middle East & Africa (MEA) |
Countries Covered | U.S., Canada, and Mexico; Germany, France, UK, Russia, Italy, Spain, and Netherlands; China, India, Japan, South Korea, and Australia; Brazil, Argentina; Saudi Arabia, UAE, Turkey, Egypt, and South Africa |
Detailed Market Segmentation
- By Type (Revenue in USD Million)
- Oral Enteral Syringe
- Nasogastric Enteral Syringe
- Jejunal Enteral Syringe
- ENFit Enteral Syringe
- By Material (Revenue in USD Million)
- Polypropylene Enteral Syringe
- Polyethylene Enteral Syringe
- By Application (Revenue in USD Million)
- Enteral Nutrition
- Medication Administration
- Fluid Therapy
- By End-Use (Revenue in USD Million)
- Hospitals
- Home Care
- Long-Term Care
- Pediatric Clinics
- By Region (Revenue in USD Million)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Central & South America
- Brazil
- Argentina
- Middle East and Africa
- Saudi Arabia
- UAE
- Turkey
- Egypt
- South Africa
- North America
